{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {},
    "annotation_url": {
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The CHRNA5/CHRNA3/CHRNB4 nicotinic receptor regulome:genomic architecture, regulatory variants, and clinical associations",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "UBERON": "^\\d+$"
    },
    "namespace_url": {
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "path": "receptors/barrie2017.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "30737823f0d248f279d75c8b1efa1e8d",
      "line": 78,
      "relation": "association",
      "source": 10,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "52b809801d07fe236c3ea28b019a79a2",
      "line": 86,
      "relation": "association",
      "source": 10,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "5f1c748b886f55e082877d3b5ecf99ea",
      "line": 88,
      "relation": "association",
      "source": 10,
      "target": 12
    },
    {
      "key": "e152732f049a618ce78a791515b94397",
      "relation": "partOf",
      "source": 10,
      "target": 3
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "462d36df257b67d1aca8449659ff4b4e",
      "line": 78,
      "relation": "association",
      "source": 0,
      "target": 10
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "a1d7412e177a6be78b988e390a4f18af",
      "line": 79,
      "relation": "association",
      "source": 0,
      "target": 9
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "533e8d273f183e7e76dc80257b5f15ab",
      "line": 79,
      "relation": "association",
      "source": 9,
      "target": 0
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "6036639e58e78e975b77a8b7c0ed90a7",
      "line": 86,
      "relation": "association",
      "source": 9,
      "target": 10
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "52bbaebe815fdd26b301d2d49c55713a",
      "line": 87,
      "relation": "association",
      "source": 9,
      "target": 12
    },
    {
      "key": "8f3378e0c17a989fd0c5aac934ba900b",
      "relation": "partOf",
      "source": 9,
      "target": 2
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "ad552bcf8c875d37c8ca423b37b8a332",
      "line": 80,
      "relation": "association",
      "source": 11,
      "target": 1
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " While CHRNA5 and CHRNA3 are expressed in multiple brain regions, CHRNB4 mRNA is detectable only in peripheral tissues; therefore, our subsequent analyses of CHRNB4 are restricted to peripheral tissues.",
      "key": "d523c0e96b9402598699b19f7eabb636",
      "line": 80,
      "relation": "association",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "da93b46f38fb05cf46239089a0f3d3c2",
      "line": 87,
      "relation": "association",
      "source": 12,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "In both tissues CHRNA3, CHRNA5, and RP11-650L12.2 are significantly co-expressed (Supp. Figure S2).",
      "key": "4813813176d2803d91818d95c4e071fc",
      "line": 88,
      "relation": "association",
      "source": 12,
      "target": 10
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " therefore, we select for further analysis the haplotype-tagging SNP rs880395, previously shown to be associated with a near fourfold increase in CHRNA5 mRNA expression in brain (Smith et al. 2011).",
      "key": "7b4d950c9e2b9b2debf843993045965f",
      "line": 96,
      "relation": "increases",
      "source": 6,
      "target": 10
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The CHRNA5-enhancer variant (marked by rs880395) predominantly affects CHRNA3, CHRNA5, and RP11-650L12.2 RNA expression in muscle and other tissues, while in the nucleus accumbens, the CHRNA3-enhancer haplotypes (rs1948) affects CHRNA3 (Figure 3A) and RP11-650L12.2 RNA.",
      "key": "0534c7383345ad00fff719a670954594",
      "line": 124,
      "relation": "increases",
      "source": 6,
      "target": 10
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The results support a protective role for the rs880395 A allele with higher expression of CHRNA5 and suggest that the rs1948 A allele, similarly causing higher expression of CHRNA3 mRNA, contributes to risk (Figure 5).",
      "key": "058d119dc7903360f4168bf48587f18c",
      "line": 156,
      "relation": "increases",
      "source": 6,
      "target": 10
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The same CHRNA5 -enhancer SNP was also the strongest signal for RP11-650L12.2 expression across several tissues, and for CHRNA3 in skeletal muscle but not in nucleus accumbens (Supp. Table S4).",
      "key": "b20e2234f3afa0b87b553fad86800003",
      "line": 104,
      "relation": "increases",
      "source": 6,
      "target": 12
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The CHRNA5-enhancer variant (marked by rs880395) predominantly affects CHRNA3, CHRNA5, and RP11-650L12.2 RNA expression in muscle and other tissues, while in the nucleus accumbens, the CHRNA3-enhancer haplotypes (rs1948) affects CHRNA3 (Figure 3A) and RP11-650L12.2 RNA.",
      "key": "74853b27e0d18be2ce638b719a2dd3f6",
      "line": 123,
      "relation": "increases",
      "source": 6,
      "target": 12
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The same CHRNA5 -enhancer SNP was also the strongest signal for RP11-650L12.2 expression across several tissues, and for CHRNA3 in skeletal muscle but not in nucleus accumbens (Supp. Table S4).",
      "key": "83326a1a532056fc2db6b5e725922e9e",
      "line": 106,
      "relation": "increases",
      "source": 6,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The same CHRNA5 -enhancer SNP was also the strongest signal for RP11-650L12.2 expression across several tissues, and for CHRNA3 in skeletal muscle but not in nucleus accumbens (Supp. Table S4).",
      "key": "76b0193ed876ca001a48108d139b0cd7",
      "line": 108,
      "relation": "causesNoChange",
      "source": 6,
      "target": 9
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The CHRNA5-enhancer variant (marked by rs880395) predominantly affects CHRNA3, CHRNA5, and RP11-650L12.2 RNA expression in muscle and other tissues, while in the nucleus accumbens, the CHRNA3-enhancer haplotypes (rs1948) affects CHRNA3 (Figure 3A) and RP11-650L12.2 RNA.",
      "key": "ece5abc721a99852282c9d9340f7d607",
      "line": 122,
      "relation": "increases",
      "source": 6,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Arteries",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Heart",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Muscle, Skeletal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Skin",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": " The CHRNA5-enhancer variant increases the nicotinic genes, but decreases PSMA4 expression in heart, artery, skin and skeletal muscle (Supp. Table S4).",
      "key": "9fa5f0185fdc3919e569ed93aefb7331",
      "line": 115,
      "relation": "decreases",
      "source": 6,
      "target": 7
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "Considering only the most significant models from the ANOVA, the minor allele (A) of rs16969968 is associated with risk of nicotine dependence, the minor allele (A) of rs880395 is protective (negative effect size), and the minor allele (A) of rs1948 is associated with risk (Table 2).",
      "key": "402aeed013391a63b34d056bf8079062",
      "line": 149,
      "relation": "decreases",
      "source": 6,
      "target": 8
    },
    {
      "key": "b4ff9207d11e6a9bb950e85340169bd8",
      "relation": "partOf",
      "source": 6,
      "target": 3
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The CHRNA5-enhancer variant (marked by rs880395) predominantly affects CHRNA3, CHRNA5, and RP11-650L12.2 RNA expression in muscle and other tissues, while in the nucleus accumbens, the CHRNA3-enhancer haplotypes (rs1948) affects CHRNA3 (Figure 3A) and RP11-650L12.2 RNA.",
      "key": "3f190b73918e800c51a10f476f014af3",
      "line": 126,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "rs1948 is associated with higher CHRNA3 expression in the nucleus accumbens (p=2.5e-17, effect size =0.99), which is further supported by considering allelic mRNA ratios (Supp. Figure S6).",
      "key": "6db952c2df3cd6b55bd1aab50931a3d5",
      "line": 134,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The results support a protective role for the rs880395 A allele with higher expression of CHRNA5 and suggest that the rs1948 A allele, similarly causing higher expression of CHRNA3 mRNA, contributes to risk (Figure 5).",
      "key": "690341f64fac2953f78bbf432bb2a910",
      "line": 158,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "MeSHAnatomy": [
          {
            "identifier": "Nucleus Accumbens",
            "namespace": "MeSHAnatomy"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The CHRNA5-enhancer variant (marked by rs880395) predominantly affects CHRNA3, CHRNA5, and RP11-650L12.2 RNA expression in muscle and other tissues, while in the nucleus accumbens, the CHRNA3-enhancer haplotypes (rs1948) affects CHRNA3 (Figure 3A) and RP11-650L12.2 RNA.",
      "key": "2ace5e80e273a0519dbe669b02e48c88",
      "line": 127,
      "relation": "increases",
      "source": 5,
      "target": 12
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "Considering only the most significant models from the ANOVA, the minor allele (A) of rs16969968 is associated with risk of nicotine dependence, the minor allele (A) of rs880395 is protective (negative effect size), and the minor allele (A) of rs1948 is associated with risk (Table 2).",
      "key": "77a9e5be99b213bbf4994cbac254587d",
      "line": 150,
      "relation": "increases",
      "source": 5,
      "target": 8
    },
    {
      "key": "b67623e2b793eae6fbe58e4d5a500efb",
      "relation": "partOf",
      "source": 5,
      "target": 2
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "Testing each SNP using ANOVA confirmed that rs16969968 is a risk factor for nicotine dependence (Bierut et al. 2008; Smith et al. 2011).",
      "key": "768c55d7271289167cd61f1ec5a260e2",
      "line": 142,
      "relation": "increases",
      "source": 4,
      "target": 8
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "Considering only the most significant models from the ANOVA, the minor allele (A) of rs16969968 is associated with risk of nicotine dependence, the minor allele (A) of rs880395 is protective (negative effect size), and the minor allele (A) of rs1948 is associated with risk (Table 2).",
      "key": "d5b2fd495c5b91523a5c26da70e9e78c",
      "line": 148,
      "relation": "increases",
      "source": 4,
      "target": 8
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The results support a protective role for the rs880395 A allele with higher expression of CHRNA5 and suggest that the rs1948 A allele, similarly causing higher expression of CHRNA3 mRNA, contributes to risk (Figure 5).",
      "key": "b86df32f60cd8ecd6b32b32a80e8438a",
      "line": 157,
      "relation": "decreases",
      "source": 3,
      "target": 8
    },
    {
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Barrie ES",
          "Frater JT",
          "Hartmann K",
          "Lee SH",
          "Sadee W",
          "Seweryn M",
          "Wang D"
        ],
        "date": "2017-01-01",
        "first": "Barrie ES",
        "identifier": "27758088",
        "journal": "Human mutation",
        "last": "Sadee W",
        "name": "The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.",
        "namespace": "pubmed",
        "pages": "112-119",
        "volume": "38"
      },
      "evidence": "The results support a protective role for the rs880395 A allele with higher expression of CHRNA5 and suggest that the rs1948 A allele, similarly causing higher expression of CHRNA3 mRNA, contributes to risk (Figure 5).",
      "key": "e26d17ad11bb4cf1dc035e99dc025126",
      "line": 159,
      "relation": "increases",
      "source": 2,
      "target": 8
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(MESH:Brain)",
      "concept": {
        "name": "Brain",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "122591e1e5a28ece8ac1124593ee701f"
    },
    {
      "bel": "a(UBERON:0000010)",
      "concept": {
        "name": "0000010",
        "namespace": "UBERON"
      },
      "function": "Abundance",
      "id": "54bbadb0be64d7d10b31e7b9f183be6d"
    },
    {
      "bel": "composite(g(DBSNP:rs1948), r(HGNC:CHRNA3))",
      "function": "Composite",
      "id": "6157894e15bd798bb82d2bf46ef2f692",
      "members": [
        {
          "bel": "g(DBSNP:rs1948)",
          "concept": {
            "name": "rs1948",
            "namespace": "DBSNP"
          },
          "function": "Gene",
          "id": "a3a934550eae29d0155232ab36e1c745"
        },
        {
          "bel": "r(HGNC:CHRNA3)",
          "concept": {
            "name": "CHRNA3",
            "namespace": "HGNC"
          },
          "function": "RNA",
          "id": "e9299c1a049e898d4329617fec914fc6"
        }
      ]
    },
    {
      "bel": "composite(g(DBSNP:rs880395), r(HGNC:CHRNA5))",
      "function": "Composite",
      "id": "be2070df41fdf0b9da007f67e4e2a420",
      "members": [
        {
          "bel": "g(DBSNP:rs880395)",
          "concept": {
            "name": "rs880395",
            "namespace": "DBSNP"
          },
          "function": "Gene",
          "id": "f701e3bad5fd756f78f482378d0fba6b"
        },
        {
          "bel": "r(HGNC:CHRNA5)",
          "concept": {
            "name": "CHRNA5",
            "namespace": "HGNC"
          },
          "function": "RNA",
          "id": "ad79309144eb1af123aa32eb2a55fe18"
        }
      ]
    },
    {
      "bel": "g(DBSNP:rs16969968)",
      "concept": {
        "name": "rs16969968",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "036c2eb804fd84913e178f2b87385b9b"
    },
    {
      "bel": "g(DBSNP:rs1948)",
      "concept": {
        "name": "rs1948",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "a3a934550eae29d0155232ab36e1c745"
    },
    {
      "bel": "g(DBSNP:rs880395)",
      "concept": {
        "name": "rs880395",
        "namespace": "DBSNP"
      },
      "function": "Gene",
      "id": "f701e3bad5fd756f78f482378d0fba6b"
    },
    {
      "bel": "p(HGNC:PSMA4)",
      "concept": {
        "name": "PSMA4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "858703de760ecfbd290f510e79e42e09"
    },
    {
      "bel": "path(MESH:\"Tobacco Use Disorder\")",
      "concept": {
        "name": "Tobacco Use Disorder",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "13c7264761719693573e94c72e68fb16"
    },
    {
      "bel": "r(HGNC:CHRNA3)",
      "concept": {
        "name": "CHRNA3",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "e9299c1a049e898d4329617fec914fc6"
    },
    {
      "bel": "r(HGNC:CHRNA5)",
      "concept": {
        "name": "CHRNA5",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "ad79309144eb1af123aa32eb2a55fe18"
    },
    {
      "bel": "r(HGNC:CHRNB4)",
      "concept": {
        "name": "CHRNB4",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "7633a561415bf7a2d7d416c4decebfa9"
    },
    {
      "bel": "r(MESH:\"long non-coding RNA RP11-650L12.2, human\")",
      "concept": {
        "name": "long non-coding RNA RP11-650L12.2, human",
        "namespace": "MESH"
      },
      "function": "RNA",
      "id": "2f10fe766953a9493fed0a29b0fe82bf"
    }
  ]
}